Sponsor or institution
Clinical trials and research at Toray Industries, Inc
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Toray Industries, Inc that are recruiting, at sites in 3 countries (most in Japan (2), South Korea (1), United States (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Combining TRK-950 with Ramucirumab and Paclitaxel for Gastric Cancer
This study is testing if adding a new drug called TRK-950 to the standard treatments ramucirumab and paclitaxel can help people with gastric cancer live longer and feel better.
-
TRK-950 for advanced solid tumors and melanoma
This trial tests whether TRK-950, alone or with the immunotherapy nivolumab, is safe in adults with advanced solid tumors or in people with unresectable or metastatic melanoma who have had prior chemotherapy.
Quick answers
How many clinical trials run by Toray Industries, Inc are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Japan (2 trials), South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.